Last updated: 30 August 2024 at 9:03pm EST

Octavio Espinoza Net Worth




The estimated Net Worth of Octavio Espinoza is at least $3.79 Milion dollars as of 28 August 2024. Octavio Espinoza owns over 753 units of Ligand Pharmaceuticals stock worth over $2,515,293 and over the last 2 years Octavio sold LGND stock worth over $1,274,940.

Octavio Espinoza LGND stock SEC Form 4 insiders trading

Octavio has made over 4 trades of the Ligand Pharmaceuticals stock since 2022, according to the Form 4 filled with the SEC. Most recently Octavio exercised 753 units of LGND stock worth $50,090 on 28 August 2024.

The largest trade Octavio's ever made was selling 13,293 units of Ligand Pharmaceuticals stock on 15 May 2024 worth over $1,146,654. On average, Octavio trades about 1,134 units every 44 days since 2022. As of 28 August 2024 Octavio still owns at least 24,399 units of Ligand Pharmaceuticals stock.

You can see the complete history of Octavio Espinoza stock trades at the bottom of the page.



What's Octavio Espinoza's mailing address?

Octavio's mailing address filed with the SEC is 555 HERITAGE DRIVE, SUITE 200, JUPITER, FL, 33458.

Insiders trading at Ligand Pharmaceuticals

Over the last 21 years, insiders at Ligand Pharmaceuticals have traded over $205,340,014 worth of Ligand Pharmaceuticals stock and bought 2,116,600 units worth $27,601,439 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog... oraz Partners L P/Ilbiotechnolog.... On average, Ligand Pharmaceuticals executives and independent directors trade stock every 22 days with the average trade being worth of $2,239,733. The most recent stock trade was executed by Octavio Espinoza on 28 August 2024, trading 753 units of LGND stock currently worth $50,090.



What does Ligand Pharmaceuticals do?

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.



What does Ligand Pharmaceuticals's logo look like?

Ligand Pharmaceuticals, Inc. logo

Complete history of Octavio Espinoza stock trades at Ligand Pharmaceuticals

Data
#
Firma
Osoba
Trans.
Transakcja
Ilość akcji Cena za akcję Łączna cena Ilość akcji po Źródło
28 Aug 2024 Octavio Espinoza
Dyrektor finansowy
Opcja Ćwiczenie 753 $66.52 $50,090
28 Aug 2024
24,399
15 May 2024 Octavio Espinoza
Dyrektor finansowy
Sprzedaż 13,293 $86.26 $1,146,654
15 May 2024
23,379
27 Feb 2024 Octavio Espinoza
Dyrektor finansowy
Opcja Ćwiczenie 1,264 $56.62 $71,568
27 Feb 2024
29,895
9 Nov 2022 Octavio Espinoza
Dyrektor finansowy
Sprzedaż 1,696 $75.64 $128,285
9 Nov 2022
8,857


Ligand Pharmaceuticals executives and stock owners

Ligand Pharmaceuticals executives and other stock owners filed with the SEC include: